Skip to main content

A python client for accessing ChEMBL web services

Motivation
The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python.

Why Python?
We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python.


Reinventing the wheel?
There are already some libraries providing access to ChEMBL data via webservices for example bioservices. These are great, but sometimes suffer from breaking as we implement required schema or implementation details. With the use of this client you can be sure that any future changes in REST API will be immediately reflected in the client. But this is not the only thing we tried to achieve.


Features
During development of the Python client we had in mind all the best practices for creating such a library. We tried to make is as easy to use and efficient as possible. Key features of this implementation are:
  • Caching results locally in sqliteDB for faster access
  • Bulk data retrieval
  • Parallel asynchronous requests to API during bulk retrieval
  • Ability to use SMILES containing URL-unsafe characters in exactly same way as safe SMILES
  • Lots of syntactic sugar
  • Extensive configuration so you can toggle caching, asynchronous requests, change timeouts, point the client to your local web services instance and much more.
These features guarantee that your code using the ChEMBL REST API will be as fast as possible (if you know of any faster way,  drop us a line and we will try to include in the code).


Demo code
OK, so let's see the live code (all examples are included in tests.py file). If you are an ipython notebook fan (like most of us) and prefer reading from notebooks instead of github gists you can click here:


So many features, just for compounds! Let's see targets:


So far, so good! What about assays?


Can I get bioactovities as well?

It's completely optional to change any settings in the ChEMBL client. We believe that default values we have chosen are optimal for most reasonable applications. However if you would like to have a play with settings to make our client work with your local webservices instance this is possible:



GET or POST?




Benchmarks

We've decided to compare our client with existing bioservices implementation. Before we describe method and results, let's say a few words about installation process. Both packages can be installed from PIP, but bioservices are quite large (1.8MB) and require dependencies not directly related to web retrieval (such as pandas or SOAPpy). On the other hand our client is rather small (<0.5 MB) and require requests, request-cache and grequests.

To compare two libraries, we've decided to measure time of retrieval first thousand of compounds with IDs from CHEMBL1 to CHEMBL1000. We've ignored 404 errors. This is how the code looks for our client:


And for bioservices:


Both snippets were run 5 times and the average time was computed.


Results:
chembl client with cache: 4.5s
chembl client no cache: 6.7s
bioservices: 9m40s


which means, that our client is 86-145 times faster than the bioservices client.


Installation and source code



Our client is already available at Python Package Index (PyPI), so in order to install it on your machine machine, you should type:

sudo pip install chembl_webresource_client

or:

pip install chembl_webresource_client

if you are using virtualenv.

The original source code is open sourced and hosted at github so you can clone it by typing:

git clone https://github.com/chembl/chembl_webresource_client.git

install latest development version, using following pip command:

sudo pip install git+https://github.com/chembl/chembl_webresource_client.git  
 
or just browse it online.


What about other programming languages?

Although we don't have plans to release a similar client library for other programming languages, examples highlighting most important API features using Perl and Java are published on Web Services homepage. And since the Web Services have CORS and JSONP support, we will publish JavaScript examples in the form of interactive API browser, so stay tuned!


Michal

Comments

Thomas Cokelaer said…
A short comment with respect to the difference of speed between BioServices and your implementation on the example provided (9 minutes instead of a few seconds sounds bad indeed).

If you use the latest version of BioServices (1.3.5), this should now be equivalent in terms of speed. The reason for the slow behaviour in previous versions was that we were waiting 1 second between requests (if the request was failing) to be nice with ChEMBL REST API.

Thomas Cokelaer, on behalf of BioServices users and developers.

BioServices on Pypi

BioServices on github

Popular posts from this blog

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and  here for a reminder of SureChEMBL is and what it does.  This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for  local (behind the

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid